Geron

Geron

Yahoo Finance • 22 days ago

Geron (GERN) Is Up 14.7% After Issuing First RYTELO Revenue Guide And Narrowing Losses - Has The Bull Case Changed?

In the second quarter of 2026, Geron Corporation reported revenue of US$57.48 million versus US$49.04 million a year earlier, a net loss of US$16.68 million, first-half revenue of US$109.32 million, and a reduced first-half net loss of US$... Full story

Yahoo Finance • 26 days ago

Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New High

(RTTNews) - Today's top biotech gainers include Attovia Therapeutics, which surged following its Nasdaq debut; American Well, after reporting a narrower loss; Perrigo, which swung back to profit; and UroGen Pharma, following strong second-... Full story

Yahoo Finance • 26 days ago

Geron Corporation Q2 2026 Earnings Call Summary

Geron Corporation Q2 2026 Earnings Call Summary - Moby Strategic Execution and Commercial Momentum Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 p... Full story

Yahoo Finance • 26 days ago

Geron Q2 Earnings Call Highlights

Key Points Interested in Geron Corporation? Here are five stocks we like better. Geron reported strong second-quarter performance, with revenue rising 17% year over year to $57.5 million and first-half revenue up approximately 24%. The co... Full story

Yahoo Finance • 27 days ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * The Walt Disney Company (DIS [https://seekingalpha.com/symbol/DIS]) * Eli Lilly and Company (LLY [https://seekingalpha.com/symbol/LLY]) * Shopify (SHOP [https://seeking... Full story

Yahoo Finance • 2 months ago

Geron (GERN) Grants Inducement Stock Options to New Employees

Geron Corporation (NASDAQ:GERN) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On June 18, 2026, Geron Corporation (NASDAQ:GERN) reported that, effective June 17, 2026, it granted stock options to purchase an aggregate of 690,... Full story

Yahoo Finance • 2 months ago

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

FOSTER CITY, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced the appointment of Chinm... Full story

Yahoo Finance • 2 months ago

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective June 17, 2026, it granted stock options to purchase an aggregate of 690... Full story

Yahoo Finance • 4 months ago

Geron Q1 Earnings Call Highlights

Geron logo Key Points Q1 net revenue of $61.8 million (up 31% YoY) and Geron reiterated full‑year Rytelo guidance of $220–240 million, noting growth is weighted to H2 2026 while gross‑to‑net rose to 21% (expected low‑mid 20s for the year... Full story

Yahoo Finance • 4 months ago

Geron Corporation (GERN) Appoints Timothy Williams as EVP, Chief Legal Officer

Geron Corporation (NASDAQ:GERN) is one of the best growth stocks under $10 to invest in. On April 13, Geron Corporation appointed Timothy Williams as Executive Vice President, Chief Legal Officer, and Corporate Secretary. A seasoned legal... Full story

Yahoo Finance • 4 months ago

Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026

FOSTER CITY, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release it... Full story

Yahoo Finance • 6 months ago

Geron Corporation Q4 2025 Earnings Call Summary

Geron Corporation Q4 2025 Earnings Call Summary - Moby Strategic Alignment and Commercial Evolution Transitioned from a clinical-stage entity to a commercially minded organization through a strategic restructuring and leadership strength... Full story

Yahoo Finance • 6 months ago

Geron Q4 Earnings Call Highlights

Geron logo Key Points Geron reported strong commercial traction for RYTELO with Q4 net revenue of $48 million, full-year 2025 sales of $184 million, and 2026 guidance of $220–$240 million, driven by 9% quarter-over-quarter demand growth,... Full story

Yahoo Finance • 6 months ago

Geron falls as Q4 results miss expectations

[Close up image of wooden cubes with alphabet Q4 on office desk.] mohd izzuan Shares of Geron Corporation (GERN [https://seekingalpha.com/symbol/GERN]) lost ~15% in the premarket on Wednesday after the cancer drug developer missed Street... Full story

Yahoo Finance • 8 months ago

Geron strategic restructuring plan focuses on Rytelo growth

[Scissors separating employees on colorful blocks representing staff reduction] * Geron said that as part of its strategic restructuring plan, it will focus [https://seekingalpha.com/pr/20336521-geron-corporation-announces-strategic-res... Full story

Yahoo Finance • 9 months ago

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemoglobin increases and transfusion independ... Full story

Yahoo Finance • 10 months ago

GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Geron (GERN) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder of Geron securities between Februar... Full story

Yahoo Finance • 10 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders... Full story

Yahoo Finance • 11 months ago

Geron Corporation Announces Executive Leadership Transitions and Appointments

FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several executive transi... Full story

Yahoo Finance • last year

SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors

ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director... Full story